Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Abbott Laboratories (ABT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 75,796,592
  • Shares Outstanding, K 1,735,270
  • Annual Sales, $ 20,853 M
  • Annual Income, $ 1,400 M
  • 36-Month Beta 0.98
  • Price/Sales 3.64
  • Price/Cash Flow 15.68
  • Price/Book 2.40

Price Performance

See More
Period Period Low Period High Performance
1-Month
42.88 +1.47%
on 05/18/17
44.90 -3.10%
on 05/08/17
-0.62 (-1.40%)
since 04/24/17
3-Month
42.31 +2.84%
on 04/17/17
45.84 -5.08%
on 03/10/17
-2.17 (-4.75%)
since 02/24/17
52-Week
36.76 +18.36%
on 06/27/16
45.84 -5.08%
on 03/10/17
+5.53 (+14.56%)
since 05/24/16

Most Recent Stories

More News
Abbott Laboratories Rises 1.15% on Heavy Volume: Watch For Potential Pullback

Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $43.10 to a high of $43.75. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high...

ABT : 43.45 (-0.53%)
Abbott Labs (ABT) Down 2.3% Since Earnings Report: Can It Rebound?

Abbott Labs (ABT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

ABT : 43.45 (-0.53%)
The Zacks Analyst Blog Highlights: General Dynamics, EOG Resources, Abbott, Northrop Grumman and Symantec

The Zacks Analyst Blog Highlights: General Dynamics, EOG Resources, Abbott, Northrop Grumman and Symantec

ABT : 43.45 (-0.53%)
NOC : 253.14 (+0.99%)
SYMC : 29.86 (+0.23%)
EOG : 92.65 (+0.13%)
GD : 200.08 (+0.38%)
Abbott Lab Well Poised on Strong EPD, St. Jude Integration

On May 17, we issued an updated research report on Abbott Laboratories (ABT).

HOLX : 43.00 (+0.26%)
EW : 114.04 (+0.44%)
ABT : 43.45 (-0.53%)
LMNX : 20.17 (-0.54%)
Analyst Reports for Abbott, EOG, General Dynamics & Others

Analyst Reports for Abbott, EOG, General Dynamics & Others

NOC : 253.14 (+0.99%)
ABT : 43.45 (-0.53%)
SYMC : 29.86 (+0.23%)
EOG : 92.65 (+0.13%)
GD : 200.08 (+0.38%)
MAR : 105.72 (+0.22%)
Infant Formula Industry Outlook 2017 Demand Supply and 2021 Opportunities and Forecasts Report - MarketReportsOnline

PUNE, India, May 15, 2017 /PRNewswire/ --

ABT : 43.45 (-0.53%)
DANOY : 14.8900 (+0.13%)
NSRGF : 84.1175 (-0.59%)
Infant Formula Industry Outlook 2017 Demand Supply and 2021 Opportunities and Forecasts Report - MarketReportsOnline

This latest report "Global Infant Formula Market" provides in-depth analysis of the infant formula market. The major trends, growth drivers as well as issues being faced by the industry are being presented...

ABT : 43.45 (-0.53%)
DANOY : 14.8900 (+0.13%)
NSRGF : 84.1175 (-0.59%)
SmarTrend Watching for Potential Rebound in Shares of Abbott Laboratories After 1.45% Loss

Abbott Laboratories (NYSE:ABT) traded in a range yesterday that spanned from a low of $43.78 to a high of $44.39. Yesterday, the shares fell 1.4%, which took the trading range below the 3-day low of...

ABT : 43.45 (-0.53%)
Research and Markets - Global Transcatheter Mitral Valve Repair and Replacement Market 2017-2022 Featuring Abbott Laboratories, Cardiac Dimensions, Edwards Lifesciences, Medtronic & Neovasc

Research and Markets has announced the addition of the "Global Transcatheter Mitral Valve Repair and Replacement (TMVR) Market - Analysis By Region, By Country: Opportunities and Forecast (2017-2022)"...

EW : 114.04 (+0.44%)
ABT : 43.45 (-0.53%)
MDT : 84.93 (+0.38%)
Abbott Announces CE Mark for TactiCath(TM) Contact Force Ablation Catheter, Sensor Enabled(TM)

Abbott (NYSE: ABT) today announced CE Mark of the TactiCath(TM) Contact Force Ablation Catheter, Sensor Enabled(TM), developed to make it easier for physicians to more effectively treat atrial fibrillation...

ABT : 43.45 (-0.53%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More

Business Summary

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. They have a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals.

See More

Support & Resistance

2nd Resistance Point 44.37
1st Resistance Point 44.03
Last Price 43.45
1st Support Level 43.48
2nd Support Level 43.27

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.